Operator
Greetings, and welcome to ClearPoint Neuro Third Quarter 2026 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.
Comments made on this call may include statements that are forward-looking within the meaning of the securities laws. These forward-looking statements may include, without limitation, statements related to anticipated industry trends, the company’s plans, prospects and strategies, both preliminary and projected, the size of total addressable markets or the market opportunity for the company’s products and services; the company’s expectation for future development, regulatory approval, timing, commercialization and the market for cell and gene therapies and the anticipated adoption of the company’s products and services for use in the delivery of gene and cell therapies and management’s expectations, beliefs, estimates or projections regarding future revenue and results of operations.
You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date on which they were made. Actual results or trends could differ materially. The company undertakes no obligation to revise forward-looking statements for new information or future events. For more information about the company’s risks and uncertainties, please refer to the company’s filings with the SEC, including the company’s recent filings on Form 8-K, Form 10-K and Form 10-Q. All the company’s filings may be obtained from the SEC or the company’s website at www.clearpointneuro.com.
I would now like to turn the conference over to your host, Mr. Joe Burnett, Chief Executive Officer. Thank
Credit: Source link
